Moderate

Perioperative management of obstructive sleep apnoea

Perioperative assessment · Perioperative & Anaesthesia
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Patients with known or suspected obstructive sleep apnoea are at increased risk of difficult airway, opioid-induced respiratory depression, postoperative hypoxaemia and cardiorespiratory events. Risk stratification (e.g. STOP-BANG), opioid-sparing analgesia, and appropriate monitoring with CPAP mitigate harm.

Red flags

  • Recurrent apnoeas or desaturation in recovery
  • Progressive sedation with opioid use (CO2 narcosis risk)
  • Signs of pulmonary hypertension/right heart failure in severe disease
  • Difficult mask ventilation or intubation at induction

Assessment

Differential diagnosis

  • Known OSA on CPAP
  • Undiagnosed OSA (high STOP-BANG, obesity, snoring, witnessed apnoeas)
  • Obesity hypoventilation syndrome
  • Postoperative opioid-induced ventilatory impairment
  • Other causes of postoperative hypoxaemia (atelectasis, residual block)

Investigations

  • STOP-BANG questionnaire to stratify risk in undiagnosed patients
  • Review of sleep study results and CPAP settings/adherence if known OSA
  • Baseline oxygen saturation and, if obesity hypoventilation suspected, arterial/venous CO2
  • ECG and assessment for pulmonary hypertension/cor pulmonale in severe long-standing disease

Management

  • Identify known and suspected OSA at preassessment and stratify severity
  • Plan opioid-sparing multimodal analgesia (regional/local, paracetamol, NSAID) and avoid long-acting sedatives
  • Anticipate a potentially difficult airway and optimise positioning (ramped) and pre-oxygenation
  • Instruct patients on CPAP to bring their machine and use it postoperatively
  • Extubate awake and sitting up; ensure full reversal of neuromuscular blockade
  • Provide extended/continuous oxygen saturation monitoring postoperatively, particularly when opioids are used
  • Avoid unmonitored opioid boluses; titrate carefully and watch for sedation and desaturation
  • Consider higher level of care for severe OSA, major surgery or significant opioid requirement

Drugs & doses

Opioid-sparing base — Paracetamol 1 g IV/oral 6-hourly plus an NSAID if no contraindication
Cautious opioid titration — Morphine 1-2 mg IV increments with close monitoring (avoid large boluses)
Antiemetic prophylaxis — Ondansetron 4 mg IV and Dexamethasone 4 mg IV
Reverse residual block fully — Sugammadex 2-4 mg/kg IV guided by train-of-four

Disposition

Low-risk patients recover on the ward with saturation monitoring; severe OSA or significant opioid needs warrant extended monitored or critical-care recovery with CPAP available.

Complications & pitfalls

  • Postoperative respiratory depression and hypoxaemia
  • Difficult airway/failed intubation
  • Cardiac arrhythmia and ischaemia
  • Unplanned critical-care admission
  • Residual neuromuscular blockade exacerbating obstruction

Exam pearls

  • Opioid-induced respiratory depression is the central hazard — build an opioid-sparing plan and monitor saturations continuously when opioids are needed
  • Use STOP-BANG to catch undiagnosed OSA, which is common and often severe in the surgical population
  • Patients should continue their own CPAP postoperatively — ask them to bring the machine
  • Extubate awake, sitting up, with fully reversed neuromuscular blockade
  • Avoid sending high-risk OSA patients to unmonitored wards with parenteral opioids

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.